ok
so all revenue so far has been based on illucix 1, an inferior product tk what has now been submitted?
does illucix 2 offer significant more revenue (ie: more practitioners will go for it, or it costs more)? Or will it be similar revenue, just a better product if(when) fda approved?
and we assume this approval might take years n tje normal fda way?
Ann: Telix Submits NDA for New Prostate Cancer Imaging Agent, page-18
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.44 |
Change
-0.320(1.54%) |
Mkt cap ! $6.967B | |||
| Open | High | Low | Value | Volume |
| $20.79 | $21.00 | $20.22 | $10.55M | 511.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2378 | $20.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.45 | 768 | 10 |
View Market Depth
| Last trade - 13.03pm 27/09/2024 (20 minute delay) ? |
| TLX (ASX) Chart |